ALNY
Alnylam Pharmaceuticals, Inc.
Biotechnology company focused on developing RNA interference-based therapeutics for rare genetic, cardio-metabolic, and infectious diseases.
CUSIP: 02043Q107HealthcareUS2 holders
Recent Activity
2025Q4
1 buy1 sell
+51.7K shares(+152.5%)
+51.7K shares(+152.5%)
-259.9K shares(-17.4%)
-259.9K shares(-17.4%)
Loading more activity...